Yamanoi K

No ORCID on file · 6 papers in corpus
observational 2026
Cancer Immunology, Immunotherapy ·doi:10.1007/s00262-026-04324-z

Transcriptomic classification methods have been proposed for ovarian clear cell carcinoma. However, their clinical significance and association with pathologically evaluated tumor-infiltrating lymphocytes (TILs) remain unclear. We establish…

case-report 2025
Cureus ·doi:10.7759/cureus.88422

Adenosarcoma is a mixed epithelial and mesenchymal neoplasm composed of a malignant mesenchymal component and a benign Müllerian glandular component. Although the endometrium is the most common primary site, adenosarcoma can also occur in t…

case-report 2025
Case reports in women's health ·doi:10.1016/j.crwh.2025.e00738

Cervical endometriosis is a rare benign condition characterized by ectopic endometrial glands and stroma within the cervix. Its clinical and imaging features resemble those of cervical adenocarcinoma, making preoperative diagnosis difficult…

case-report 2025
International cancer conference journal ·doi:10.1007/s13691-024-00739-6

The combination therapy of lenvatinib plus pembrolizumab (LP) is increasingly recognized as an important second-line regimen for advanced or recurrent endometrial cancer (EC). However, the safety and efficacy of conversion surgery with low …

review 2021
Cancers ·doi:10.3390/cancers13102413

Clear cell carcinoma (CCC) of the ovary exhibits a unique morphology and clinically malignant behavior. The eosinophilic cytoplasm includes abundant glycogen. Although the growth is slow, the prognosis is poor owing to resistance to convent…

case-report 2019
Gynecology and Minimally Invasive Therapy ·doi:10.4103/gmit.gmit_18_19

We report a case of synchronous primary corpus and ovarian cancer (SPC) with massive ascites due to Pseudo-Meigs syndrome (PMS). A 48-year-old woman presented with complaints of abnormal genital bleeding and abdominal discomfort. Massive as…